Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | NQO1 | P15559 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 3/20 | 0.37 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.37 |
| ▸ | CTRC | Q99895 | 2/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.36 |
| ▸ | TYMP | P19971 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8627682 | 0.74 | CALM1 (0.42) | ALDH1A1RAB9ASMN1; SMN2TDP1CALM1 | |
| SCHEMBL25372606 | 0.72 | LMNA (0.44) | MAOBALDH1A1KDM4EHTTRAB9A | |
| Ammonia Solution, Strong SCHEMBL27829594 | 0.71 | LMNA (0.43) | MAOBALDH1A1KDM4EHTTRAB9A | |
| SCHEMBL311581 | 0.71 | CTRC (0.40) | MAOBALDH1A1KDM4EHTTRAB9A | |
| SCHEMBL28190794 | 0.71 | KDM4E (0.48) | MAOBALDH1A1KDM4EMAPK1RAB9A | |
| SCHEMBL23925707 | 0.71 | HDAC4 (0.53) | MAOBALDH1A1KDM4EMAPK1HTT | |
| SCHEMBL812897 | 0.67 | CTRC (0.48) | MAOBALDH1A1KDM4EMAPK1HTT | |
| SCHEMBL5562618 | 0.67 | SLC5A2 (0.47) | MAOBALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL27429798 | 0.67 | CTRC (0.53) | RAB9ASMN1; SMN2CALM1CTRCPTPN1 | |
| SCHEMBL9419609 | 0.67 | CALM1 (0.42) | MAOBALDH1A1MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10993917-B2 | Nanocomplex | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2021-05-04 | — | — | US | disclosed |
| EP-3142705-B1 | POLYMER-FLAVONOID CONJUGATE AND USES THEREOF | AGENCY SCIENCE TECH & RES (SG) | 2020-08-19 | — | — | EP | disclosed |
| EP-2435504-B1 | FLAVONOID HYDROGEL | AGENCY SCIENCE TECH & RES (SG) | 2020-03-11 | — | — | EP | disclosed |
| US-10406175-B2 | Polymer-flavonoid conjugate and uses thereof | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-09-10 | — | — | US | disclosed |
| US-20190262271-A1 | A NANOCOMPLEX | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-08-29 | — | — | US | disclosed |
| US-10221253-B2 | Phase separated composite | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2019-03-05 | — | — | US | disclosed |
| WO-2018124970-A1 | A NANOCOMPLEX | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2018-07-05 | — | — | WO | disclosed |
| US-20170258757-A1 | ANTI-CANCER AGENT DELIVERY VEHICLES CAPABLE OF IMPROVED LOADING | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-09-14 | — | — | US | disclosed |
| US-20170216446-A1 | POLYMER-FLAVONOID CONJUGATE AND USES THEREOF | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-08-03 | — | — | US | disclosed |
| US-9687464-B2 | Anti-cancer agent delivery vehicles capable of improved loading | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2017-06-27 | — | — | US | disclosed |
| CN-101909655-A | Method of delivering an anti-cancer agent to a cell | AGENCY SCIENCE TECH & RES | 2010-12-08 | — | — | CN | disclosed |
| WO-2010138082-A1 | FLAVONOID HYDROGEL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-12-02 | — | — | WO | disclosed |
| EP-2214715-A1 | METHOD OF DELIVERING AN ANTI-CANCER AGENT TO A CELL | Agency for Science, Technology And Research (SG) | 2010-08-11 | — | — | EP | disclosed |
| US-20100075926-A1 | ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-03-25 | — | — | US | disclosed |
| WO-2010011318-A2 | ACTIVATIQN OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-01-28 | — | — | WO | disclosed |
| WO-2009054813-A1 | METHOD OF DELIVERING AN ANTI-CANCER AGENT TO A CELL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-04-30 | — | — | WO | disclosed |
| CN-101180319-A | Aldehyde conjugated flavonoid preparations | AGENCY SCIENCE TECH & RES (SG) | 2008-05-14 | — | — | CN | disclosed |
| US-20080102052-A1 | ALDEHYDE CONJUGATED FLAVONOID PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH | 2008-05-01 | — | — | US | disclosed |
| EP-1888651-A1 | ALDEHYDE CONJUGATED FLAVONOID PREPARATIONS | Agency for Science, Technology and Research (SG) | 2008-02-20 | — | — | EP | disclosed |
| WO-2006124000-A1 | ALDEHYDE CONJUGATED FLAVONOID PREPARATIONS | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2006-11-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10221253-B2 | Phase separated composite | COL2A1, COL1A1, COL14A1 | MAOB 145/4885NQO1 1008/4885ALDH1A1 213/4885 |
| US-10993917-B2 | Nanocomplex | CD44, PROC, MUC1 | MAOB 1928/4885NQO1 71/4885ALDH1A1 678/4885 |
| US-20170216446-A1 | POLYMER-FLAVONOID CONJUGATE AND USES THEREOF | SYVN1, SELP, PCSK6 | MAOB 418/4885NQO1 18/4885ALDH1A1 2541/4885 |
| US-20100075926-A1 | ACTIVATION OF HISTONE DEACETYLASE 1 (HDAC1) PROTECTS AGAINST DNA DAMAGE AND INCREASES NEURONAL SURVIVAL | GRIK5, HDAC11, GRIK1 | MAOB 736/4885NQO1 1982/4885ALDH1A1 2825/4885 |
| US-10406175-B2 | Polymer-flavonoid conjugate and uses thereof | SYVN1, SELP, PCSK6 | MAOB 418/4885NQO1 18/4885ALDH1A1 2541/4885 |
| US-20190262271-A1 | A NANOCOMPLEX | CD44, MUC1, PROC | MAOB 1459/4885NQO1 57/4885ALDH1A1 610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.